918
Views
40
CrossRef citations to date
0
Altmetric
Drug Evaluation

Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence

, , &
Pages 95-102 | Received 01 Jun 2018, Accepted 06 Nov 2018, Published online: 15 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Ling Tang, Xiu-Xiu Liu, Xiao-Dan Yang, Shuang Tan & Zhong-Wen Zou. (2023) A compound formulation of EGF-modified paclitaxel micelles and EGF-modified emodin micelles enhance the therapeutic effect of ovarian cancer. Journal of Liposome Research 33:1, pages 89-101.
Read now
Chao Pi, Wenmei Zhao, Mingtang Zeng, Jiyuan Yuan, Hongping Shen, Ke Li, Zhilian Su, Zerong Liu, Jie Wen, Xinjie Song, Robert J. Lee, Yumeng Wei & Ling Zhao. (2022) Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo. Drug Delivery 29:1, pages 1878-1891.
Read now
Khushwant S. Yadav, Archana Upadhya & Ambikanandan Misra. (2021) Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers). Expert Opinion on Drug Delivery 18:1, pages 103-118.
Read now
Shizhen Zheng, Chao Wang, Hao Yan & Yuejun Du. (2021) Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis. Bioengineered 12:1, pages 8347-8357.
Read now
Yue Yang, Yunjian Li, Kai Chen, Ling Zhang, Sen Qiao, Guoxin Tan, Fen Chen & Weisan Pan. (2020) Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy. International Journal of Nanomedicine 15, pages 2885-2902.
Read now
Pu Guo, Yingmeng He, Ting Xu, Chao Pi, Qingsheng Jiang, Yumeng Wei & Ling Zhao. (2020) Co-delivery system of chemotherapy drugs and active ingredients from natural plants: a brief overview of preclinical research for cancer treatment. Expert Opinion on Drug Delivery 17:5, pages 665-675.
Read now
Willie O Pinheiro, Maria L Fascineli, Gabriel R Farias, Frederico H Horst, Laise Rodrigues de Andrade, Luis Henrique Corrêa, Kelly Grace Magalhães, Marcelo Henrique Sousa, Marcos C de Almeida, Ricardo B Azevedo & Zulmira G M Lacava. (2019) The influence of female mice age on biodistribution and biocompatibility of citrate-coated magnetic nanoparticles. International Journal of Nanomedicine 14, pages 3375-3388.
Read now

Articles from other publishers (33)

Haiyang Dong, Lu Lu, Xueting Song, Youkang Li, Jinguang Zhou, Yungen Xu, Yahong Zhang, Jianguo Qi, Tingting Liang & Jianhong Wang. (2023) Design, synthesis and biological evaluation of tetrahydroquinoxaline sulfonamide derivatives as colchicine binding site inhibitors. RSC Advances 13:43, pages 30202-30216.
Crossref
Jingjing Chai, Junfei Zhu, Yu Tian, Kui Yang, Jiajie Luan & Yan Wang. (2023) Carbon monoxide therapy: a promising strategy for cancer. Journal of Materials Chemistry B 11:9, pages 1849-1865.
Crossref
Aditi Sharma, Lalit Sharma, Shouvik Kumar Nandy, Nazrana Payal, Shivam Yadav, Celia Vargas-De-La-Cruz, Md. Khalid Anwer, Haroon Khan, Tapan Behl & Simona Gabriela Bungau. (2023) Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer. Molecules 28:2, pages 750.
Crossref
Sudipto Saha, Sreyashi Majumdar & Parthasarathi BhattacharyyaSudipto Saha, Sreyashi Majumdar & Parthasarathi Bhattacharyya. 2023. Pulmonomics: Omics Approaches for Understanding Pulmonary Diseases. Pulmonomics: Omics Approaches for Understanding Pulmonary Diseases 363 405 .
Chenglong Wang, Xiaolin Xu, Peipei Zhang, Shuhan Xiong, Jia Yuan, Xuzhu Gao, Wencai Guan, Fanchen Wang, Xin Li, Hongjing Dou & Guoxiong Xu. (2022) Lipid-coated albumin-paclitaxel nanoparticles loaded with sorcin-siRNA reverse cancer chemoresistance via restoring intracellular calcium ion homeostasis. Journal of Nanobiotechnology 20:1.
Crossref
Meiling Sun, Huaijun Ji, Ning Xu, Peng Jiang, Tao Qu & Yu Li. (2022) Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma. BMC Cancer 22:1.
Crossref
Fang Li, Stacy Yeh, Qin Shi, Peng Wang, Hongyan Wu & Junbo Xin. (2022) A Novel Thermal-driven Self-assembly Method to Prepare Albumin Nanoparticles: Formation Kinetics, Degradation Behavior and Formation Mechanism. AAPS PharmSciTech 23:7.
Crossref
Youwei Huang, Xiangyu Wang, Rendong Hu, Guopeng Pan & Xi Lin. (2022) SOX2 regulates paclitaxel resistance of A549 non‑small cell lung cancer cells via promoting transcription of ClC‑3. Oncology Reports 48:4.
Crossref
Chengming Liu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Xinfeng Wang, Lu Yang, Haiyan Xu, Zheng Cao, Xiaoli Feng, Qi Xue, Yan Wang, Nan Sun & Jie He. (2022) KRAS ‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer . Cancer Communications 42:9, pages 828-847.
Crossref
Jun Zhang, Zhijia Tang, Xi Guo, Yunxia Wang, Yuhong Zhou & Weimin Cai. (2022) Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene. Frontiers in Oncology 12.
Crossref
Xiaojun Ye, Xiangliang Liu, Na Yin, Wei Song, Jin Lu, Yi Yang & Xiao Chen. (2022) Successful first-line treatment of simultaneous multiple primary malignancies of lung adenocarcinoma and renal clear cell carcinoma: A case report. Frontiers in Immunology 13.
Crossref
Robert C. Sabatelle, Rong Liu, Yin P. Hung, Eric Bressler, Eliza J. Neal, Andrew Martin, Iriny Ekladious, Mark W. Grinstaff & Yolonda L. Colson. (2022) Ultra-high drug loading improves nanoparticle efficacy against peritoneal mesothelioma. Biomaterials 285, pages 121534.
Crossref
Yangsong Zuo, Wenyi Shen, Lili Wang, Chengshi Wang & Juan Pu. (2022) Study on the Mechanism of Action of Paclitaxel-Loaded Polylactic-co-glycolic Acid Nanoparticles in Non-Small-Cell Lung Carcinoma Cells. Computational and Mathematical Methods in Medicine 2022, pages 1-7.
Crossref
Matthew C Phillips & Shaker A Mousa. (2022) Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management. Nanomedicine 17:6, pages 405-421.
Crossref
Nahal Habibi, Ava Mauser, Yeongun Ko & Joerg Lahann. (2022) Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches. Advanced Science 9:8.
Crossref
Xue Cui, Min Peng & Honglei Chen. (2022) The Emerging Role of Lymphocyte Activation Gene 3 in the Cancer Immunotherapy. Oncologie 24:4, pages 665-678.
Crossref
Mariam Alexander, Elaine Shum, Aditi Singh & Balazs Halmos. 2023. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer 321 346 .
Alessandro Bittoni, Riccardo Giampieri, Federica Pecci, Giada Pinterpe, Alessandra Mandolesi, Michela Del Prete, Antonio Zizzi, Sonia Crocetti, Carolina Liguori, Giulia Mentrasti, Luca Cantini, Chiara Pellei, Renato Bisonni, Marina Scarpelli & Rossana Berardi. (2021) Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients. Current Oncology 28:5, pages 3525-3536.
Crossref
Xin Luan, Hebao Yuan, Yudong Song, Hongxiang Hu, Bo Wen, Miao He, Huixia Zhang, Yan Li, Feng Li, Pan Shu, Joseph P. Burnett, Nathan Truchan, Maria Palmisano, Manjunath P. Pai, Simon Zhou, Wei Gao & Duxin Sun. (2021) Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation. Biomaterials 275, pages 120910.
Crossref
Xiaoping Li, Yiling Feng, Bo Yang, Ting Xiao, Haixia Ren, Xi Yu, Lei Li, Mingjiang Li & Weidong Zhang. (2021) A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR‐558. Molecular Oncology 15:8, pages 2235-2248.
Crossref
Kinga Byk, Filip Charuk, Ewa Olędzka, Marcin Sobczak & Monika Zielińska-Pisklak. (2021) ZASTOSOWANIA KLINICZNE PAKLITAKSELU W TERAPII NOWOTWORÓW. Prospects in Pharmaceutical Sciences 19:2, pages 9-17.
Crossref
Wang Yao, Jialiang Yao, Fangfang Qian, Zujun Que, Pan Yu, Tianle Luo, Dan Zheng, Zhanxia Zhang & Jianhui Tian. (2021) Paclitaxel-loaded and folic acid-modified PLGA nanomedicine with glutathione response for the treatment of lung cancer. Acta Biochimica et Biophysica Sinica 53:8, pages 1027-1036.
Crossref
Yonglu Li, Xiaodong Zheng & Qiang Chu. (2021) Bio-based nanomaterials for cancer therapy. Nano Today 38, pages 101134.
Crossref
Jhih-Wei Huang, Ching-Hua Kuo, Han-Chun Kuo, Jin-Yuan Shih, Teng-Wen Tsai & Lin-Chau Chang. (2021) Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel. PLOS ONE 16:3, pages e0248942.
Crossref
Jhih-Wei Huang, Ching-Hua Kuo, Han-Chun Kuo, Jin-Yuan Shih, Teng-Wen Tsai & Lin-Chau Chang. (2021) Differences in Fatty Acid Oxidation between Nab -Paclitaxel- and Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics . ACS Omega 6:8, pages 5138-5145.
Crossref
Agnese Gagliardi, Elena Giuliano, Eeda Venkateswararao, Massimo Fresta, Stefania Bulotta, Vibhudutta Awasthi & Donato Cosco. (2021) Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors. Frontiers in Pharmacology 12.
Crossref
Farong Zang, Yuanquan Rao, Xinhai Zhu, Zhibing Wu & Hao Jiang. (2020) Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer. Molecular Medicine 26:1.
Crossref
Minghuan Gao, Tong Liu, Jingnan Li, Qi Guan, Haoran Wang, Shuqi Yan, Zengqiang Li, Daiying Zuo, Weige Zhang & Yingliang Wu. (2020) YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells. Toxicology in Vitro 69, pages 104971.
Crossref
Zelai He, Huijun Zhang, Hongwei Li, Yanyan Wang, Jing Qian, Xixi Cai, Li Sun & Jingwen Huang. (2020) Preparation, Biosafety, and Cytotoxicity Studies of a Newly Tumor-Microenvironment-Responsive Biodegradable Mesoporous Silica Nanosystem Based on Multimodal and Synergistic Treatment. Oxidative Medicine and Cellular Longevity 2020, pages 1-14.
Crossref
Ramon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo-Branco & Victor André de Almeida Zia. (2020) New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives. Journal of Clinical Medicine 9:11, pages 3543.
Crossref
Duxin Sun, Simon Zhou & Wei Gao. (2020) What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right. ACS Nano 14:10, pages 12281-12290.
Crossref
Vijay Sagar Madamsetty, Manash K. Paul, Anubhab Mukherjee & Sudip Mukherjee. (2019) Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics. ACS Biomaterials Science & Engineering 6:1, pages 167-181.
Crossref
Romina Mitarotonda, Exequiel Giorgi, Martín F. Desimone & Mauricio C. De Marzi. (2019) Nanoparticles and Immune Cells. Current Pharmaceutical Design 25:37, pages 3960-3982.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.